PATENT CLAIM ANALYSIS

Application Number: 16222155
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of combinations of immunomodulatory polynucleotides (e.g., mRNAs) encoding an immune response primer polypeptide (e.g., an interleukin 23 (IL-23) polypeptide or an interleukin 36γ (IL-36-gamma) polypeptide), and an immune response co-stimulatory signal polypeptide (e.g., an OX40L polypeptide).

Claim (Index 11):
The lipid nanoparticle of  claim 10 , wherein the sterol is cholesterol and the PEG-modified lipid is PEG-DMG.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.73684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16184282', '16219418', '15995889', '16192274', '15996146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8654461797032335
- 35 USC 102 Novelty (BERT): 0.6400983931374364
- Combined Prediction Score: 0.8429114010466537
- Mean Citation Score: 685.9833299999998
- Max Citation Score: 814.3477
- Similarity Product: 551.0139936705768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test